Radiobiological and immunohistochemical assessment of hypoxia in human melanoma xenografts: Acute and chronic hypoxia in individual tumours

International Journal of Radiation Biology

Volumn 75, Issue 11, 1999, Pages 1377-1393

  Rofstad, E K ^a   Maseide K ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

PIMONIDAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER RADIOTHERAPY; CANCER RESISTANCE; CANCER TRANSPLANTATION; CELL HYPOXIA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOBIOLOGY; RADIOSENSITIVITY;

EID: 0032698303     PISSN: 09553002     EISSN: None     Source Type: Journal    
DOI: 10.1080/095530099139250     Document Type: Article

References (67)

1. ADAMS, G. E., HASAN, N. M. and JOINER, M. C., 1997, Radiation, hypoxia and genetic stimulation; implications for future therapies. Radiotherapy and Oncology, 44, 101-109.
2. ARTEEL, G. E., THURMAN, R. G., YATES, J. M. and RALEIGH, J. A., 1995, Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion in rat livers. British Journal of Cancer, 72, 889-895.
3. AZUMA, C., RALEIGH, J. A. and THRALL, D. E., 1997, Longevity of pimonidazole adducts in spontaneous canine tumors as an estimate of hypoxic cell lifetime. Radiation Research, 148, 35-42.
4. BRIZEL, D. M., SCULLY, S. P., HARRELSON, J. M., LAYFIELD, L. J., BEAN, J. M., PROSNITZ, L. R. and DEWHIRST, M. W., 1996, Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Research, 56, 941-943.
5. BRIZEL, D. M., SIBLEY, G. S., PROSNITZ, L. R., SCHER, R. L. and DEWHIRST, M. W., 1997, Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. International Journal of Radiation Oncology, Biology, Physics, 38, 285-289.
6. CHAPLIN, D. J. and HORSMAN, M. R., 1992, Tumor blood flow changes induced by chemical modifiers of radiation response. International Journal of Radiation Oncology, Biology, Physics, 22, 459-462.
7. CHAPMAN, J. D., LEE, J. and MEEKER, B. E., 1989, Keynote address: cellular reduction of nitroimidazole drugs: potential for selective chemotherapy and diagnosis of hypoxic cells. International Journal of Radiation Oncology, Biology, Physics, 16, 911-917.
8. CLINE, J. M., THRALL, D. E., PAGE, R. L., FRANKO, A. J. and RALEIGH, J. A., 1990, Immuno-histochemical detection of a hypoxia marker in spontaneous canine tumours. British Journal of Cancer, 62, 925-931.
9. CLINE, J. M., THRALL, D. E., ROSNER, G. L. and RALEIGH, J. A., 1994, Distribution of the hypoxia marker CC1-103F in canine tumors. International Journal of Radiation Oncology, Biology, Physics, 28, 921-933.
10. COLEMAN, C. N., 1988, Hypoxia in tumors: a paradigm for the approach to biochemical and physiologic heterogeneity. Journal of the National Cancer Institute, 80, 310-317.
11. DANIELSEN, T. and ROFSTAD, E. K., 1998, VEGF, bFGF and EGF in the angiogenesis of human melanoma xenografts. International Journal of Cancer, 76, 836-841.
12. DEGNER, F. L. and SUTHERLAND, R. M., 1988, Mathematical modelling of oxygen supply and oxygenation in tumor tissues: prognostic, therapeutic, and experimental implications. International Journal of Radiation Oncology, Biology, Physics, 15, 391-397.
13. DENEKAMP, J., DASU, A., WAITES, A. and LITTBRAND, B., 1998, Hyperfractionation as an effective way of overcoming radioresistance. International Journal of Radiation Oncology, Biology, Physics, 42, 705-709.
14. DEWHIRST, M. W., KIMURA, H., REHMUS, S. W. E., BRAUN, R. D., PAPAHADJOPOULOS, D., HONG, K. and SECOMB, T. W., 1996, Microvascular studies on the origins of perfusion-limited hypoxia. British Journal of Cancer, 74 (suppl. XXVII), s247-251.
15. DURAND, R. E. and LEPARD, N. E., 1995, Contribution of transient blood flow to tumour hypoxia in mice. Acta Oncologica, 34, 317-323.
16. DURAND, R. E. and RALEIGH, J. A., 1998, Identification of nonproliferating but viable hypoxic tumor cells in vivo. Cancer Research, 58, 3547-3550.
17. EVANS, S. M., JENKINS, W. T., JOINER, B., LORD, E. M. and KOCH, C. J., 1996, 2-Nitroimidazole (EF5) binding predicts radiation resistance in individual 9L s.c. tumors. Cancer Research, 56, 405-411.
18. EVANS, S. M., JOINER, B., JENKINS, W. T., LAUGHLIN, K. M., LORD, E. M. and KOCH, C. J., 1995, Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide]. British Journal of Cancer, 72, 875-882.
19. FENTON, B. M., KIANI, M. F. and SIEMANN, D. W., 1995, Should direct measurements of tumor oxygenation relate to the radiobiological hypoxic fraction of a tumor? International Journal of Radiation Oncology, Biology, Physics, 33, 365-373.
20. FRANKO, A. J., KOCH, C. J. and BOISVERT, D. P. J., 1992, Distribution of misonidazole adducts in 9L gliosarcoma tumors and spheroids: implications for oxygen distribution. Cancer Research, 52, 3831-3837.
21. GILLESPIE, C. J., CHAPMAN, J. D., REUVERS, A. P. and DUGLE D. L., 1975, The inactivation of Chinese hamster cells by X rays: synchronized and exponential cell populations. Radiation Research, 64, 353-364.
22. GROEBE, K. and VAUPEL, P., 1988, Evaluation of oxygen diffusion distances in human breast cancer xenografts using tumor-specific in vivo data: role of various mechanisms in the development of tumor hypoxia. International Journal of Radiation Oncology, Biology, Physics, 15, 691-697.
23. HILL, R. P., 1990, Tumor progression: potential role of unstable genomic changes. Cancer Metastasis Reviews, 9, 137-147.
24. HODGKISS, R. J., JONES, G., LONG, A., PARRICK, J., SMITH, K. A., STRATFORD, M. R. L. and WILSON, G. D., 1991, Flow cytometric evaluation of hypoxic cells in solid experimental tumours using fluorescence immunodetection. British Journal of Cancer, 63, 119-125.
25. HORSMAN, M. R., 1995, Nicotinamide and other benzamide analogs as agents for overcoming hypoxic cell radiation resistance in tumours. Acta Oncologica, 34, 571-587.
26. 2 predicts survival in advanced cancer of the uterine cervix. Radiotherapy and Oncology, 26, 45-50.
27. HÖCKEL, M., SCHLENGER, K., ARAL, B., MITZE, M., SCHÄFFER, U. and VAUPEL, P., 1996, Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Research, 56, 4509-4515.
28. 3H]misonidazole binding and paired survival assay. Radiation Research, 145, 491-500.
29. KENNEDY, A. S., RALEIGH, J. A., PEREZ, G. M., CALKINS, D. P., THRALL, D. E., NOVOTNY, D. B. and VARIA, M. A., 1997, Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays. International Journal of Radiation Oncology, Biology, Physics, 37, 897-905.
30. KIM, I. H., LEMMON, M. J. and BROWN, J. M., 1993, The influence of irradiation of the tumor bed on tumor hypoxia: measurements by radiation response, oxygen electrodes, and nitro-imidazole binding. Radiation Research, 135, 411-417.
31. KIMURA, H., BRAUN, R. D., ONG, E. T., HSU, R., SECOMB, T. W., PAPAHADJOPOULOS, D., HONG, K. and DEWHIRST, M. W., 1996, Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. Cancer Research, 56, 5522-5528.
32. LEE, J., SIEMANN, D. W., KOCH, C. J. and LORD, E. M., 1996, Direct relationship between radiobiological hypoxia in tumors and monoclonal antibody detection of EF5 cellular adducts. International Journal of Cancer, 67, 372-378.
33. LORD, E. M., HARWELL, L. and KOCH, C. J., 1993, Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts. Cancer Research, 53, 5721-5726.
34. MOULDER, J. E. and ROCKWELL, S., 1984, Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data. International Journal of Radiation Oncology, Biology, Physics, 10, 695-712.
35. MUELLER-KLIESER, W., SCHLENGER, K.-H., WALENTA, S., GROSS, M., KARBACH, U., HOECKEL, M. and VAUPEL, P., 1991, Pathophysiological approaches to identifying tumor hypoxia in patients. Radiotherapy and Oncology, Suppl. 20, 21-28.
36. NORDSMARK, M., OVERGAARD, M. and OVERGAARD, J., 1996, Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiotherapy and Oncology, 41, 31-39.
37. OVERGAARD, J., 1989, Sensitization of hypoxic tumour cells clinical experience. International Journal of Radiation Biology, 56, 801-811.
38. OVERGAARD, J. and HORSMAN, M. R., 1993, Overcoming hypoxic cell radioresistance. In G. G. Steel (ed.), Basic Clinical Radiobiology for Radiation Oncologists (London: Edward Arnold), pp. 163-172.
39. RALEIGH, J. A., CALKINS-ADAMS, D. P., RINKER, L. H., BALLENGER, C. A., WEISSLER, M. C., FOWLER, W. C., NOVOTNY, D. B. and VARIA, M. A., 1998a, Hypoxia and vascular endothelial growth factor protein expression in human tumors. Cancer Research, 58, 3765-3768.
40. RALEIGH, J. A., CHOU, S. C., TABLES, L., SUCHINDRAN, S., VARIA, M. A. and HORSMAN, M. R., 1998b, Relationship of hypoxia to metallothioncin expression in murine tumors. International Journal of Radiation Oncology, Biology, Physics, 42, 727-730.
41. RALEIGH, J. A., DEWHIRST, M. W. and THRALL, D. E., 1996, Measuring tumor hypoxia. Seminars in Radiation Oncology, 6, 37-45.
42. RALEIGH, J. A., MILLER, G. G., FRANKO, A. J., KOCH, C. J., FUCIARELLI, A. F. and KELLY, D. A., 1987, Fluorescence immunohistochemical detection of hypoxic cells in spheroids and tumours. British Journal of Cancer, 56, 395-400.
43. RASEY, J. S., KOH, W., GRIERSON, J. R., GRUNBAUM, Z. and KROHN, K. A., 1989, Radiolabeled fluoromisonidazole as an imaging agent for tumor hypoxia. International Journal of Radiation Oncology, Biology, Physics, 17, 985-991.
44. REYNOLDS, T. Y., ROCKWELL, S. and GLAZER, P. M., 1996, Genetic instability induced by the tumor microenvironment. Cancer Research, 56, 5754-5757.
45. ROCKWELL, S. and MOULDER, J. E., 1990, Hypoxic fractions of human tumors xenografted into mice: a review. International Journal of Radiation Oncology, Biology, Physics, 19, 197-202.
46. ROFSTAD, E. K., 1994, Orthotopic human melanoma xenograft model systems for studies of tumour angiogenesis, pathophysiology, treatment sensitivity and metastatic pattern. British Journal of Cancer, 70, 804-812.
47. ROFSTAD, E. K. and DANIELSEN, T., 1998, Hypoxia-induced angiogenesis and vascular endothelial growth factor secretion in human melanoma. British Journal of Cancer, 77, 897-902.
48. ROFSTAD, E. K. and DANIELSEN, T., 1999, Hypoxia-induced metastasis of human melanoma cells: involvement of vascular endothelial growth factor-mediated angiogenesis. British Journal of Cancer, 80, 1697-1707.
49. SANNA, K. and ROFSTAD, E. K., 1994, Hypoxia-induced resistance to doxorubicin and methotrexate in human melanoma cells in vitro. International Journal of Cancer, 58, 258-262.
50. SMITHEN, C. E. and HARDY, C. R., 1982, The chemistry of nitroimidazole hypoxic cell radio-sensitizers. In A. Breccia, C. Rimondi and G. E. Adams (eds), Advanced Topics on Radiosensitizers of Hypoxic Cells (New York: Plenum), pp. 1-47.
51. STONE, H. B., BROWN, J. M., PHILLIPS, T. L. and SUTHERLAND, R. M., 1993, Oxygen in human tumors: correlations between methods of measurement and response to therapy. Radiation Research, 136, 422-434.
52. SUNDFØR, K., LYNG, H. and ROFSTAD, E. K., 1998, Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix. British Journal of Cancer, 78, 822-827.
53. SUTHERLAND, R. M., AUSSERER, W. A., MURPHY, B. J. and LADEROUTE, K. R., 1996, Tumor hypoxia and heterogeneity: challenges and opportunities for the future. Seminars in Radiation Oncology, 6, 59-70.
54. TANNOCK, I. F., 1972, Oxygen diffusion and the distribution of cellular radiosensitivity in tumors. British Journal of Radiology, 45, 515-524.
55. TEICHER, B. A., 1994, Hypoxia and drug resistance. Cancer Metastasis Reviews, 13, 139-168.
56. TROTTER, M. J., CHAPLIN, D. J., DURAND, R. E. and OLIVE, P. L., 1989, The use of fluorescent probes to identify regions of transient perfusion in murine tumors. International Journal of Radiation Oncology, Biology, Physics, 16, 931-934.
57. TROTTER, M. J., CHAPLIN, D. J. and OLIVE, P. L., 1991, Possible mechanisms for intermittent blood flow in the murine SCCVII carcinoma. International Journal of Radiation Biology, 60, 139-146.
58. TUFTO, I., LYNG, H. and ROFSTAD, E. K., 1998, Vascular density in human melanoma xenografts: relationship to angiogenesis, perfusion and necrosis. Cancer Letters, 123, 159-165.
59. TUFTO, I. and ROFSTAD, E. K., 1995, Transient perfusion in human melanoma xenografts. British Journal of Cancer, 71, 789-793.
60. 3H-misonidazole to solid human tumors as a measure of tumor hypoxia. International Journal of Radiation Oncology, Biology, Physics, 12, 1263-1267
61. VARIA, M. A., CALKINS-ADAMS, D. P., RINKER, L. H., KENNEDY, A. S., NOVOTNY, D. B., FOWLER, W. C. and RALEIGH, J. A., 1998, A novel hypoxia marker for comptementary study of tumor hypoxia and cell proliferation in cervical carcinoma. Gynecologic Oncology, 71, 270-277.
62. VAUPEL, P., 1990, Oxygenation of human tumors. Strahlentherapie und Onkologie, 166, 377-386.
63. WEIBEL, E. R., 1979, Stereological Methods (London: Academic).
64. WOODS, M. L., KOCH, C. J. and LORD, E. M., 1996, Detection of individual hypoxic cells in multicellular spheroids by flow cytometry using the 2-nitroimidazole, EF5, and monoclonal antibodies. International Journal of Radiation Oncology, Biology, Physics, 34, 93-101.
65. WOUTERS, B. G. and BROWN, J. M., 1997, Cells at intermediate oxygen levels can be more important than the 'hypoxic fraction' in determining tumor response to fractionated radiotherapy. Radiation Research, 147, 541-550.
66. YOUNG, S. D., MARSHALL, R. S. and HILL, R. P., 1988, Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proceedings of the National Academy of Sciences, USA, 85, 9533-9537.
67. ZEMAN, E. M., CALKINS, D. P., CLINE, J. M., THRALL, D. E. and RALEIGH, J. A., 1993, The relationship between proliferative and oxygenation status in spontaneous canine tumors. International Journal of Radiation Oncology, Biology, Physics, 27, 891-898.